[1]
Y. Y. Dzhun, Y. Y. Marushko, Y. A. Saienko, N. M. Rudenko, and B. M. Mankovsky, “The Clinical Effect of Dapagliflozin in Patients with Angiographically Confirmed Coronary Artery Disease and Concomitant Type 2 Diabetes Mellitus”, ujcvs, vol. 30, no. 3, pp. 35-43, Sep. 2022.